Faron Confirms Plans for the Coming Months Under New Leadership
GlobeNewswire
· Initial data from ongoing Phase 2 part of BEXMAB trial anticipated next month
· Incoming CEO, Juho Jalkanen, to..
· Initial data from ongoing Phase 2 part of BEXMAB trial anticipated next month
· Incoming CEO, Juho Jalkanen, to..
*NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in..